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Abstract
Introduction:  Though gastrointestinal stromal tumors (GISTs) frequently present with
gastrointestinal bleeding, the guidelines for the management and control of bleeding are unclear
especially in patients who are not appropriate for surgical resection.
Case presentation: We report a case of gastric GIST in an elderly patient who presented with
bleeding. Homeostasis was achieved initially with the endoscopic placement of a hemoclip followed
by treatment with the tyrosine kinase inhibitor, imatinib.
Conclusion: The management of bleeding GISTs in the elderly pose a challenging task to the
gastroenterologist and treatment strategies should be tailored to the expertise of the endoscopist,
surgeon and other supportive staff.
Introduction
Mesenchymal tumors are an infrequently encountered
group of benign and malignant neoplasms of the gas-
trointestinal tract. Gastrointestinal stromal tumors
(GISTs), account for the majority of these gastrointestinal
mesenchymal tumors. Mazur and Clark [1] first recog-
nized GISTs as a separate entity from gastrointestinal
smooth muscle tumors in 1983 based on the different cel-
lular origin, the intestinal pacemaker cells of Cajal for the
former, and the smooth muscle cells for the latter. GISTs
are often asymptomatic and discovered incidentally dur-
ing endoscopic procedures. GI-related symptoms nor-
mally occur with larger tumors. Several major GIST-
related symptoms are bleeding, abdominal pain, abdom-
inal mass and obstruction. When such complications
occur, surgical resection is generally recommended. In
this paper, we describe the case of an 84 year-old man
who presented with melena and bleeding from a gastric
GIST. Surgical intervention was prohibited due to other
concomitant medical illnesses. However, the bleeding
was successfully controlled with hemoclip application.
The management of gastrointestinal bleeding from GISTs
is also reviewed.
Case presentation
An 84-year-old man had an incidental finding of a stomach
mass on an abdominal CT scan performed in preparation
for an inguinal hernia repair. Esophagogastroduodenos-
copy (EGD) was performed and showed a gastric deformity
suggestive of a subepithelial tumor rather than extrinsic
compression. Endoscopic ultrasound (EUS) showed an
intramural (subepithelial) lesion in the greater curvature
of the stomach, 3 cm distal to the gastroesophageal junc-
tion measuring 44 mm × 59 mm. EUS-guided fine needle
aspiration was performed and cytological examination
showed spindle shaped cells that stained positive for c-kit.
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The cytomorphological and immunocytological findings
were suggestive of a diagnosis of gastrointestinal stromal
tumor (GIST). Shortly after the diagnosis, the patient pre-
sented to our emergency department with a one week his-
tory of epigastric pain, melena and dizziness. Upon
examination, his temperature was 37.4°C, pulse 72 beats/
min, respirations 18 times/min, and blood pressure 164/
78 while lying down and 105/71 while standing. The
patient was alert and oriented. Laboratory tests revealed
the following values: hemoglobin 10.6 g/dl (normal 12–
15) and hematocrit 31.5% (normal 35–49). His basic
metabolic profile, coagulation profile and liver function
tests were all normal. He was resuscitated with intrave-
nous fluids and transfused with two units of packed red
blood cells. Repeat EGD showed the GIST tumor with
deep ulceration and visible bleeding vessels (Figure 1).
Homeostasis was achieved with placement of two hemo-
clips (Figure 2). The patient was evaluated by the general
surgery team and deemed not a good surgical candidate
due to his age and severe coronary artery disease. He was
started on imatinib (Gleevec; Novartis Pharmaceuticals
Corporation, East Hanover, NJ) 400 mg daily by mouth in
accordance with oncology recommendations. Patient was
discharged home with no further gastrointestinal bleed-
ing. Upon follow up five months later, the patient was
continuing to do well with no further episodes of gas-
trointestinal bleeding. His follow up hemoglobin was
13.4 g/dL and hematocrit 39%. Repeat upper endoscopy
showed significant reduction in the size of the tumor. The
previously identified ulcers were completely healed (Fig-
ure 3, arrow head).
Discussion
Approximately 2000–5000 cases of GIST are diagnosed
annually. The predominant site for a GIST is the stomach
(52%), followed by the small intestine (25%) [2]. The
clinical presentation of a GIST largely depends on its size.
Small tumors (usually measuring less than 2 cm) usually
do not produce symptoms and are often detected inciden-
Repeat upper endoscopy 5 months after the episode of  bleeding showed significant reduction of the tumor size and  the previously identified ulcers were completely healed  (arrow head) Figure 3
Repeat upper endoscopy 5 months after the episode of 
bleeding showed significant reduction of the tumor size and 
the previously identified ulcers were completely healed 
(arrow head).
EGD showed the gastric mass with deep ulceration and  bleeding visible vessels Figure 1
EGD showed the gastric mass with deep ulceration and 
bleeding visible vessels.
Homeostasis was achieved with placement of two hemoclips  during upper endoscopy Figure 2
Homeostasis was achieved with placement of two hemoclips 
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tally on endoscopy or radiographic examination. Approx-
imately one-third of patients present with GI bleeding.
Bleeding can be occult and manifest as anemia, or overt
and manifest as melena, hematochezia or hematemesis
[3].
The standard therapy for GISTs regardless of presentation
is complete surgical resection. In general, only a segmen-
tal resection of the organ in which the tumor originates is
necessary. Meticulous surgical technique is essential as
these tumors are fragile and tumor rupture increases the
risk of peritoneal recurrence. Although complete resection
is achieved in 85 % of patients, the 5-year survival after
resection is approximately 50 % because of tumor recur-
rence [3,4]. Thus other treatment modalities in addition
to surgical resection are needed to improve the treatment
outcome. The discovery that dysregulation in the KIT tyro-
sine kinase activity underlies the pathogenesis of GIST has
led to the development of a novel systemic tyrosine kinase
inhibitor, imatinib[5]. This medication has revolution-
ized the treatment of this tumor particularly in patients
who have metastatic and/or unresectable disease.
Currently, there are no guidelines on the management of
patients with GIST presenting with acute upper GI bleed-
ing. The initial evaluation includes an assessment of
hemodynamic stability and resuscitation, if necessary.
Therapeutic endoscopy is usually performed in cases of
active GI bleeding. In this report, hemoclips were used
and hemostasis was achieved. Because of the paucity of
data on the management of actively bleeding GIST with
hemoclips, we searched MEDLINE for literature pub-
lished between January 1966 and February 2007 to com-
pile the outcome of treating bleeding GISTs with
hemoclips. The terms utilized in the search were gastroin-
testinal stromal tumor, gastrointestinal hemorrhage,
bleeding, management, and clips/hemoclips. Reference
lists of the identified articles were also reviewed to find
additional cases. Although there are several reports of
small intestinal and colonic GISTs presenting with acute
GI bleeding, we identified only five case reports of six
patients with stomach GIST presenting with acute GI
bleeding [6-10]. One report of two patients is published
in Italian [6]. Hemoclips were not used in any of these
cases although there is a single case report of hemoclip use
to control bleeding from an ulcerated duodenal GIST
[11]. We report the first case of stomach GIST presenting
with acute GI bleeding and treated with hemoclip applica-
tion. The four cases that were published in English
included three men and one woman with a mean age of
68.2 years (range, 50–77 years) [7-10] (Table 1). The clin-
ical presentations of each patient are described in Table 1.
No details regarding endoscopic interventions were pro-
vided; all patients underwent surgery to control the bleed-
ing lesions.
Since surgery was prohibited in our case due to other co-
morbidities, imatinib was given after endoscopic treat-
ment. The reason for this approach was twofold. First, this
medication has proven efficacy in patients with metastatic
disease who are usually treated non-surgically[12]. Sec-
ond, it was given with the intent to cause regression of the
size of the tumor and prevent future bleeding. In fact,
upon repeating upper endoscopy three months after-
wards, we found significant reduction in the size of the
tumor and the ulcers were completely healed.
Conclusion
In a clinical scenario when surgical resection is not an
option in the management of bleeding gastric GIST, the
use of hemoclips, if feasible, should be considered. The
therapy should be followed by imatinib with the goal to
stabilize the tumor growth and lead to regression of the
size of the tumor. The management of bleeding gastroin-
testinal stromal tumors in the elderly poses a challenge to
the gastroenterologist and treatment strategies should be
tailored to the expertise of the endoscopists, surgeons, and
other supportive staff members.
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Table 1: Clinical Data of four patients with stomach GIST presenting with acute GI bleeding
Year (reference) Age (y)/sex Clinical presentation Treatment
2005 [7] 50/F Recurrent upper GI bleed Total gastrectomy, partial 
hepatectomy and esophagectomy
2005 [8] 72/M Chest discomfort and syncope Partial gastrectomy
2005 [9] 74/M Hematemesis and melena Partial gastrectomy
2006 [10] 72/M Coffee ground vomiting Partial gastrectomyPublish with BioMed Central    and   every 
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